There is an urgent need for effective treatments for coronavirus disease-2019 (COVID-19). Amiodarone, like hydroxychloroquine, exerts antiviral actions by interfering with endocytosis and viral replication. Here, to our knowledge, we report the first case of a patient affected by respiratory failure related to COVID-19 who recovered after only supportive measures and a short amiodarone course. ().
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259916 | PMC |
| http://dx.doi.org/10.1016/j.jaccas.2020.04.053 | DOI Listing |
Publication Analysis
Top Keywords
safety efficacy
4
efficacy amiodarone
4
amiodarone patient
4
patient covid-19
4
covid-19 urgent
4
urgent effective
4
effective treatments
4
treatments coronavirus
4
coronavirus disease-2019
4
disease-2019 covid-19
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!